Pfizer seeks fast-track approval for vaccine in India
May 27, 2021
119
1
0.84%
Search the Record
IndexedEvery word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
Mirror Now Episodes Around May 27, 2021
See what was published immediately before and after this episode.
2:44Now PlayingPfizer seeks fast-track approval for vaccine in India
YouTube Description
as posted by the channelUS pharma major Pfizer is seeking fast-track approval for its coronavirus vaccine in India as it has claimed to the Centre that its COVID-19 vaccine is highly effective against the new COVID-19 strain prevalent in India. The company informed the Indian authorities that its vaccine has demonstrated 'high effectiveness' against the COVID-19 variant and on the people of Indian ethnicity or nationality adding that its vaccine is also suitable for everyone aged 12 years or above and can be preserved for a month at 2-8 degrees. Pfizer had earlier proposed an of offer 5 crore dosages to the Centre it was between July and October this year. Watch!
SUBSCRIBE NOW for more such videos ►
For More Updates ►
Like us on Facebook ►
Follow us on Twitter ►
Follow us on Instagram ►
Links & Promotions
Guests & Subjects Covered
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.